Avantax Planning Partners’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,652
Closed -$218K 445
2024
Q4
$218K Hold
1,652
0.01% 400
2024
Q3
$241K Sell
1,652
-10
-0.6% -$1.46K 0.01% 379
2024
Q2
$228K Hold
1,662
0.01% 414
2024
Q1
$228K Buy
1,662
+29
+2% +$3.98K 0.01% 419
2023
Q4
$222K Sell
1,633
-85
-5% -$11.5K 0.01% 343
2023
Q3
$210K Hold
1,718
0.01% 341
2023
Q2
$218K Hold
1,718
0.01% 343
2023
Q1
$222K Sell
1,718
-550
-24% -$71K 0.01% 341
2022
Q4
$298K Hold
2,268
0.01% 301
2022
Q3
$265K Sell
2,268
-41
-2% -$4.79K 0.01% 294
2022
Q2
$272K Buy
2,309
+335
+17% +$39.5K 0.01% 285
2022
Q1
$257K Buy
1,974
+283
+17% +$36.8K 0.01% 305
2021
Q4
$258K Buy
1,691
+42
+3% +$6.41K 0.01% 298
2021
Q3
$267K Hold
1,649
0.01% 273
2021
Q2
$270K Buy
1,649
+78
+5% +$12.8K 0.01% 270
2021
Q1
$237K Hold
1,571
0.01% 275
2020
Q4
$238K Hold
1,571
0.01% 253
2020
Q3
$213K Sell
1,571
-1,423
-48% -$193K 0.01% 272
2020
Q2
$409K Buy
2,994
+38
+1% +$5.19K 0.02% 193
2020
Q1
$319K Hold
2,956
0.02% 197
2019
Q4
$356K Sell
2,956
-166
-5% -$20K 0.02% 212
2019
Q3
$311K Buy
3,122
+29
+0.9% +$2.89K 0.02% 224
2019
Q2
$333K Buy
3,093
+78
+3% +$8.4K 0.02% 221
2019
Q1
$337K Sell
3,015
-645
-18% -$72.1K 0.02% 215
2018
Q4
$353K Hold
3,660
0.03% 174
2018
Q3
$446K Buy
3,660
+1,682
+85% +$205K 0.04% 147
2018
Q2
$217K Sell
1,978
-874
-31% -$95.9K 0.02% 222
2018
Q1
$304K Hold
2,852
0.03% 227
2017
Q4
$305K Sell
2,852
-2,287
-45% -$245K 0.03% 226
2017
Q3
$571K Sell
5,139
-396
-7% -$44K 0.05% 187
2017
Q2
$572K Sell
5,535
-285
-5% -$29.5K 0.05% 178
2017
Q1
$569K Buy
5,820
+1,260
+28% +$123K 0.05% 165
2016
Q4
$403K Buy
+4,560
New +$403K 0.04% 191